|55.00||+1.87 / +3.52%|
As of 4:00pm ET
|55.74||+0.74 / +1.35%|
The 11 analysts offering 12-month price forecasts for PTC Therapeutics Inc have a median target of 91.00, with a high estimate of 155.00 and a low estimate of 63.00. The median estimate represents a +65.45% increase from the last price of 55.00.
The current consensus among 11 polled investment analysts is to Buy stock in PTC Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.